{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:08:14Z","timestamp":1775153294752,"version":"3.50.1"},"reference-count":28,"publisher":"American Association for Cancer Research (AACR)","issue":"3","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although monoallelic expression (MAE) is a frequent genomic event in normal tissues, its role in tumorigenesis remains unclear. Here we carried out single-nucleotide polymorphism arrays on DNA and RNA from a large cohort of pediatric and adult brain tumor tissues to determine the genome-wide rate of MAE, its role in specific cancer-related genes, and the clinical consequences of MAE in brain tumors. We also used targeted genotyping to examine the role of tumor-related genes in brain tumor development and specifically examined the clinical consequences of MAE at TP53 and IDH1. The genome-wide rate of tumor MAE was higher than in previously described normal tissue and increased with specific tumor grade. Oncogenes, but not tumor suppressors, exhibited significantly higher MAE in high-grade compared with low-grade tumors. This method identified nine novel genes highly associated with MAE. Within cancer-related genes, MAE was gene specific; hTERT was most significantly affected, with a higher frequency of MAE in adult and advanced tumors. Clinically, MAE at TP53 exists only in mutated tumors and increases with tumor aggressiveness. MAE toward the normal allele at IDH1 conferred worse survival even in IDH1 mutated tumors. Taken together, our findings suggest that MAE is tumor and gene specific, frequent in brain tumor subtypes, and may be associated with tumor progression\/aggressiveness. Further exploration of MAE at relevant genes may contribute to better understanding of tumor development and determine survival in brain tumor patients. Cancer Res; 72(3); 636\u201344. \u00a92011 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-11-2266","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T20:43:09Z","timestamp":1323117789000},"page":"636-644","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Monoallelic Expression Determines Oncogenic Progression and Outcome in Benign and Malignant Brain Tumors"],"prefix":"10.1158","volume":"72","author":[{"given":"Erin J.","family":"Walker","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"},{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]},{"given":"Cindy","family":"Zhang","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"},{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]},{"given":"Pedro","family":"Castelo-Branco","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"},{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]},{"given":"Cynthia","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"},{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]},{"given":"Wes","family":"Wilson","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"},{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]},{"given":"Nataliya","family":"Zhukova","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"},{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]},{"given":"Noa","family":"Alon","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]},{"given":"Ana","family":"Novokmet","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]},{"given":"Berivan","family":"Baskin","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]},{"given":"Peter","family":"Ray","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]},{"given":"Christiane","family":"Knobbe","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]},{"given":"Peter","family":"Dirks","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]},{"given":"Michael D.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]},{"given":"Sidney","family":"Croul","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"},{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]},{"given":"David","family":"Malkin","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]},{"given":"Uri","family":"Tabori","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"},{"name":"Authors' Affiliations:\u20081Division of Haematology\/Oncology, 2The Labatt Brain Tumor Research Centre, Departments of 3Pathology, 4Pediatric and Laboratory Medicine, The Hospital for Sick Children; and 5Department of Neuropathology, Toronto General Hospital, Toronto, Ontario, Canada"}]}],"member":"1086","published-online":{"date-parts":[[2012,1,31]]},"reference":[{"key":"2022061703491555600_bib1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0092-8674(94)90562-2","article-title":"Allelic inactivation regulates olfactory receptor gene expression","volume":"78","author":"Chess","year":"1994","journal-title":"Cell"},{"key":"2022061703491555600_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.0105-2896.2004.00158.x","article-title":"Monoallelic gene expression: a repertoire of recurrent themes","volume":"200","author":"Goldmit","year":"2004","journal-title":"Immunol Rev"},{"key":"2022061703491555600_bib3","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1126\/science.1148910","article-title":"Widespread monoallelic expression on human autosomes","volume":"318","author":"Gimelbrant","year":"2007","journal-title":"Science"},{"key":"2022061703491555600_bib4","doi-asserted-by":"crossref","first-page":"e13556","DOI":"10.1371\/journal.pone.0013556","article-title":"Evaluation of allelic expression of imprinted genes in adult human blood","volume":"5","author":"Frost","year":"2010","journal-title":"PLoS One"},{"key":"2022061703491555600_bib5","doi-asserted-by":"crossref","first-page":"e1293","DOI":"10.1371\/journal.pone.0001293","article-title":"Monoallelic expression of multiple genes in the CNS","volume":"2","author":"Wang","year":"2007","journal-title":"PLoS One"},{"key":"2022061703491555600_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/humu.21248","article-title":"Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease","volume":"31","author":"Voutsinas","year":"2010","journal-title":"Hum Mutat"},{"key":"2022061703491555600_bib7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/hmg\/ddp537","article-title":"Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer","volume":"19","author":"Pinheiro","year":"2010","journal-title":"Hum Mol Genet"},{"key":"2022061703491555600_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4161\/cbt.7.1.5199","article-title":"Allele-specific expression in the germline of patients with familial pancreatic cancer: an unbiased approach to cancer gene discovery","volume":"7","author":"Tan","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"2022061703491555600_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gr.083931.108","article-title":"Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation","volume":"19","author":"Milani","year":"2009","journal-title":"Genome Res"},{"key":"2022061703491555600_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1152\/physiolgenomics.00163.2003","article-title":"A survey of genetic and epigenetic variation affecting human gene expression","volume":"16","author":"Pastinen","year":"2004","journal-title":"Physiol Genomics"},{"key":"2022061703491555600_bib11","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/neuonc\/nop066","article-title":"Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology","volume":"12","author":"Porter","year":"2010","journal-title":"Neuro Oncol"},{"key":"2022061703491555600_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11910-010-0103-9","article-title":"The genetics of pediatric brain tumors","volume":"10","author":"Dubuc","year":"2010","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2022061703491555600_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.5858\/2010-0649-RAIR.1","article-title":"Molecular diagnostics of gliomas","volume":"135","author":"Nikiforova","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"2022061703491555600_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1750-3639.2008.00225.x","article-title":"Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene","volume":"19","author":"Sievert","year":"2009","journal-title":"Brain Pathol"},{"key":"2022061703491555600_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/neuonc\/nop001","article-title":"Genome-wide profiling using single-nucleotide polymorphism arrays identifies novel chromosomal imbalances in pediatric glioblastomas","volume":"12","author":"Qu","year":"2010","journal-title":"Neuro Oncol"},{"key":"2022061703491555600_bib16","first-page":"145","article-title":"Genomic imprinting syndromes and cancer","author":"Lim","year":"2010"},{"key":"2022061703491555600_bib17","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.stem.2009.03.014","article-title":"Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens","volume":"4","author":"Pollard","year":"2009","journal-title":"Cell Stem Cell"},{"key":"2022061703491555600_bib18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ng.407","article-title":"Genome-wide association study identifies five susceptibility loci for glioma","volume":"41","author":"Shete","year":"2009","journal-title":"Nat Genet"},{"key":"2022061703491555600_bib19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ng.408","article-title":"Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility","volume":"41","author":"Wrensch","year":"2009","journal-title":"Nat Genet"},{"key":"2022061703491555600_bib20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","year":"2008","journal-title":"Nature"},{"key":"2022061703491555600_bib21","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.2009.26.8169","article-title":"TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors","volume":"28","author":"Tabori","year":"2010","journal-title":"J Clin Oncol"},{"key":"2022061703491555600_bib22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-008-0455-2","article-title":"Analysis of the IDH1 codon 132 mutation in brain tumors","volume":"116","author":"Balss","year":"2008","journal-title":"Acta Neuropathologica"},{"key":"2022061703491555600_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1470-2045(10)70053-X","article-title":"Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?","volume":"12","author":"Kloosterhof","year":"2011","journal-title":"Lancet Oncol"},{"key":"2022061703491555600_bib24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N Engl J Med"},{"key":"2022061703491555600_bib25","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"2022061703491555600_bib26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/cdd.2009.202","article-title":"Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo","volume":"17","author":"Lambertz","year":"2010","journal-title":"Cell Death Differ"},{"key":"2022061703491555600_bib27","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1101\/gad.1777409","article-title":"The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo","volume":"23","author":"Huse","year":"2009","journal-title":"Genes Dev"},{"key":"2022061703491555600_bib28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00401-010-0781-z","article-title":"Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas","volume":"120","author":"Hartmann","year":"2010","journal-title":"Acta Neuropathologica"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/72\/3\/636\/2678383\/636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/72\/3\/636\/2678383\/636.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T08:33:33Z","timestamp":1655454813000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/72\/3\/636\/578030\/Monoallelic-Expression-Determines-Oncogenic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,31]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,1,31]]},"published-print":{"date-parts":[[2012,2,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-11-2266","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22393235.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22393241.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22393250","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22393241","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22393253","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22393244","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22393256.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22393256","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22393235","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22393250.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22393247","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22393238","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22393247.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22393253.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22393244.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22393238.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6503723.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6503723","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,31]]}}}